Close Menu
    What's Hot

    Zscaler, Together With Bharti Airtel, Announce Launch of AI & Cyber Threat Research Center to Advance Cyber Resilience and Trusted AI Adoption

    February 21, 2026

    Airtel launches new AI-powered protection from ‘frauds caused by OTP leakages’

    February 11, 2026

    Häfele India Opens Its Largest-Ever Flagship Design Centre in Gurugram

    February 6, 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Finance KhabarFinance Khabar
    • Home
    • Fixed Deposit
    • Personal Loan
    • Home Loan
    • Mutual Fund
    • Insurance
    • Credit Card
    • Equities
    • M&A
    • Start Ups
    • Banks
    • Others
      • P R
    Finance KhabarFinance Khabar
    Home»Featured»Mankind Pharma launches drug to treat black fungus
    Featured

    Mankind Pharma launches drug to treat black fungus

    Finance KhabarBy Finance KhabarJune 10, 2021No Comments1 Min Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Mankind Pharma launches drug to treat black fungus
    Share
    Facebook Twitter LinkedIn Pinterest Email

    New Delhi: Mankind Pharma on Thursday said it has launched Posaconazole Gastro resistant tablets, used to treat black fungus, in the country. The company has launched the drug under the brand name Posaforce 100.

    “As the cases of black fungus are increasing day by day, the product has been launched to fight against this infection. The drug firm always strives to launch affordable medicines with an endeavour to achieve the best quality standards in the pharmaceutical industry,” Mankind Pharma said in a statement.

    The country has seen more than 12,000 cases of deadly black fungus (mucormycosis), so far with Gujarat, Maharashtra, Andhra Pradesh, Madhya Pradesh and Telangana, accounting for the maximum number of cases.

    Posaconazole has been found to be a safer and effective drug of choice for the management of the disease. The drug has received approval from the Drug Controller General of India (DCGI), the drug maker noted

    Besides, AIIMS and ICMR have also recommended use of Posaconazole as an effective option for the management of mucormycosis, it added.

    mankind farma
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleHDFC to raise up to Rs 2,000 cr by issuing bonds
    Next Article Tata Digital to acquire majority stake in 1MG
    Finance Khabar

    Related Posts

    TotalEnergies Plans to Exit India’s Renewable Sector, Looks to Cut Spending

    September 30, 2025

    Amit Shah to Attend FE Best Banks Awards in Mumbai

    September 25, 2025

    SEBI and RBI Plan Easier Rules for Foreign Investors

    September 23, 2025
    Add A Comment

    Comments are closed.

    Top Posts

    Zscaler, Together With Bharti Airtel, Announce Launch of AI & Cyber Threat Research Center to Advance Cyber Resilience and Trusted AI Adoption

    February 21, 2026

    Airtel launches new AI-powered protection from ‘frauds caused by OTP leakages’

    February 11, 2026

    Häfele India Opens Its Largest-Ever Flagship Design Centre in Gurugram

    February 6, 2026

    Subscribe to Updates

    Stay in the know with Finance Khabar! Never miss a beat when it comes to the latest in finance, investing, and personal finance tips.

    Thank you for choosing Finance Khabar as your go-to resource for all things finance. We're here to help you achieve financial success!

    Facebook X (Twitter) Instagram
    Quick Links
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    • Term And Conditions
    Copyright © 2026 FINANCE KHABAR. All Rights Reserved

    Type above and press Enter to search. Press Esc to cancel.